Treace Medical Concepts, Inc.

NASDAQ:TMCI

7.94 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 68.70845.08644.45551.10862.21240.75841.95342.19549.76933.05529.96729.04733.43921.61920.65418.70724.10514.2667.73911.256
Cost of Revenue 13.2318.9548.78110.12711.4697.9987.6758.0399.7426.6245.2915.5066.3074.2483.9443.3275.0842.9112.0852.389
Gross Profit 55.47736.13235.67440.98150.74332.7634.27834.15640.02726.43124.67623.54127.13217.37116.7115.3819.02111.3555.6548.867
Gross Profit Ratio 0.8070.8010.8020.8020.8160.8040.8170.8090.8040.80.8230.810.8110.8040.8090.8220.7890.7960.7310.788
Reseach & Development Expenses 5.214.9635.1575.2594.1524.353.5263.4123.7493.7992.9843.0523.3772.5372.4221.8681.9221.5110.9821.433
General & Administrative Expenses 13.61213.52814.21814.36213.44912.68610.03110.86510.4068.9167.0156.6627.0274.314.3292.7662.0391.8041.4011.295
Selling & Marketing Expenses 36.85932.77537.68140.32839.92433.54233.77333.65529.36925.03426.6121.92322.32515.98414.0112.14811.4258.1034.7897.338
SG&A 50.47146.30351.89954.6953.37346.22843.80444.5239.77533.9533.62528.58529.35220.29418.33914.91413.4649.9076.198.633
Other Expenses 000.1120.0740.0960.0230.0950.1280-0.045-0.0030.00200000000
Operating Expenses 55.68151.26657.05659.94957.52550.57847.3347.93243.52437.74936.60931.63732.72922.83120.76116.78215.38611.4187.17210.066
Operating Income -0.204-15.134-21.382-18.968-6.782-17.818-13.052-13.776-3.497-11.318-11.933-8.096-5.597-5.46-4.051-1.4023.635-0.063-1.518-1.199
Operating Income Ratio -0.003-0.336-0.481-0.371-0.109-0.437-0.311-0.326-0.07-0.342-0.398-0.279-0.167-0.253-0.196-0.0750.151-0.004-0.196-0.107
Total Other Income Expenses Net -0.297-0.2260.1760.2920.5010.2970.7810.322-0.915-0.815-5.301-0.94-1.022-0.958-1.032-1.03-1.068-2.592-0.455-0.408
Income Before Tax -0.501-15.36-21.206-18.676-6.281-17.521-12.271-13.454-4.412-12.133-17.234-9.036-6.619-6.418-5.083-2.4322.567-2.655-1.973-1.607
Income Before Tax Ratio -0.007-0.341-0.477-0.365-0.101-0.43-0.292-0.319-0.089-0.367-0.575-0.311-0.198-0.297-0.246-0.130.106-0.186-0.255-0.143
Income Tax Expense 0001.8660.509-1.5641.377-0.322-0.9170.8150.9430.941.0280.0050.0060.001-1.74600.0030.033
Net Income -0.501-15.36-21.206-18.676-6.281-17.521-12.271-13.132-3.495-12.948-17.234-9.976-6.619-6.418-5.083-2.4322.406-2.655-1.973-1.607
Net Income Ratio -0.007-0.341-0.477-0.365-0.101-0.43-0.292-0.311-0.07-0.392-0.575-0.343-0.198-0.297-0.246-0.130.1-0.186-0.255-0.143
EPS -0.008-0.25-0.34-0.3-0.1-0.28-0.2-0.22-0.063-0.23-0.31-0.18-0.12-0.12-0.1-0.0480.051-0.061-0.045-0.037
EPS Diluted -0.008-0.25-0.34-0.3-0.1-0.28-0.2-0.22-0.063-0.23-0.31-0.18-0.12-0.12-0.1-0.0480.051-0.061-0.045-0.037
EBITDA 3.05-11.89-17.778-15.45-3.208-14.661-9.256-10.619-2.184-10.484-15.036-7.751-5.315-5.266-3.945-1.2843.8430.272-1.155-0.895
EBITDA Ratio 0.044-0.264-0.433-0.334-0.081-0.437-0.236-0.267-0.062-0.317-0.38-0.267-0.167-0.244-0.191-0.0690.0870.019-0.149-0.077